These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10356144)

  • 1. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.
    Bertrand Y; Landais P; Friedrich W; Gerritsen B; Morgan G; Fasth A; Cavazzana-Calvo M; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Haddad E; Fischer A
    J Pediatr; 1999 Jun; 134(6):740-8. PubMed ID: 10356144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.
    Haddad E; Landais P; Friedrich W; Gerritsen B; Cavazzana-Calvo M; Morgan G; Bertrand Y; Fasth A; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Fischer A
    Blood; 1998 May; 91(10):3646-53. PubMed ID: 9573000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA non-identical T-cell-depleted bone marrow transplantation for primary immunodeficiency diseases.
    Giri N; Vowels M; Ziegler JB; Ford D; Lam-Po-Tang R
    Aust N Z J Med; 1994 Feb; 24(1):26-30. PubMed ID: 8002854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European experience of bone-marrow transplantation for severe combined immunodeficiency.
    Fischer A; Landais P; Friedrich W; Morgan G; Gerritsen B; Fasth A; Porta F; Griscelli C; Goldman SF; Levinsky R
    Lancet; 1990 Oct; 336(8719):850-4. PubMed ID: 1976883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients.
    Haddad E; Le Deist F; Aucouturier P; Cavazzana-Calvo M; Blanche S; De Saint Basile G; Fischer A
    Blood; 1999 Oct; 94(8):2923-30. PubMed ID: 10515898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.
    O'Marcaigh AS; DeSantes K; Hu D; Pabst H; Horn B; Li L; Cowan MJ
    Bone Marrow Transplant; 2001 Apr; 27(7):703-9. PubMed ID: 11360109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center.
    Gennery AR; Dickinson AM; Brigham K; Barge D; Spickett GP; Curtis A; Spencer V; Jackson A; Cavanagh G; Carter V; Palmer P; Flood TJ; Cant AJ; Abinun M
    Cytotherapy; 2001; 3(3):221-32. PubMed ID: 12171729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.
    Hartnett BJ; Yao D; Suter SE; Ellinwood NM; Henthorn PS; Moore PE; McSweeney PA; Nash RA; Brown JD; Weinberg KI; Felsburg PJ
    Biol Blood Marrow Transplant; 2002; 8(4):188-97. PubMed ID: 12014808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation.
    Cavazzana-Calvo M; Bensoussan D; Jabado N; Haddad E; Yvon E; Moskwa M; Tachet des Combes A; Buisson M; Morand P; Virion JM; Le Deist F; Fischer A
    Br J Haematol; 1998 Nov; 103(2):543-51. PubMed ID: 9827933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report.
    Fischer A; Friedrich W; Fasth A; Blanche S; Le Deist F; Girault D; Veber F; Vossen J; Lopez M; Griscelli C
    Blood; 1991 Jan; 77(2):249-56. PubMed ID: 1985691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.
    Smogorzewska EM; Brooks J; Annett G; Kapoor N; Crooks GM; Kohn DB; Parkman R; Weinberg KI
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):111-8. PubMed ID: 10807052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation for severe combined immune deficiency.
    Grunebaum E; Mazzolari E; Porta F; Dallera D; Atkinson A; Reid B; Notarangelo LD; Roifman CM
    JAMA; 2006 Feb; 295(5):508-18. PubMed ID: 16449616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation.
    Dror Y; Gallagher R; Wara DW; Colombe BW; Merino A; Benkerrou M; Cowan MJ
    Blood; 1993 Apr; 81(8):2021-30. PubMed ID: 8471764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matched unrelated bone marrow transplantation for combined immunodeficiency.
    Dalal I; Reid B; Doyle J; Freedman M; Calderwood S; Saunders F; Roifman CM
    Bone Marrow Transplant; 2000 Mar; 25(6):613-21. PubMed ID: 10734295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients.
    Bertrand Y; Müller SM; Casanova JL; Morgan G; Fischer A; Friedrich W
    Bone Marrow Transplant; 2002 May; 29(9):759-62. PubMed ID: 12040473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating red cells usually remain of host origin after bone marrow transplantation for severe combined immunodeficiency.
    Brady KA; Cowan MJ; Leavitt AD
    Transfusion; 1996 Apr; 36(4):314-7. PubMed ID: 8623130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
    Keller MD; Chen DF; Condron SA; Liu N; Reinsmoen NL; Buckley RH
    J Clin Immunol; 2007 Jan; 27(1):109-16. PubMed ID: 17191149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.